Assessing the accuracy of a new hand hygiene monitoring device (SmartRub®): from the laboratory to clinical practice.


Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
06 11 2021
Historique:
received: 02 03 2021
accepted: 17 09 2021
entrez: 7 11 2021
pubmed: 8 11 2021
medline: 1 3 2022
Statut: epublish

Résumé

We developed SmartRub® powered by iQati®, an electronic device composed of a wristband and an alcohol-based handrub pocket-sized dispenser that measures and provides feedback on the duration of hand friction and the volume poured during each hand hygiene action. We aimed to assess the accuracy of SmartRub®. The specificity, sensitivity, positive and negative predictive values (PPV and NPV) of SmartRub® were assessed in a 3-phased experiment: (1) laboratory-controlled conditions with volunteers; (2) pre-planned clinical path with volunteers and (3) real clinical conditions with healthcare workers. The accuracy of SmartRub® was evaluated by quantifying its ability to correctly capture true hand hygiene actions and to not record other actions performed while wearing the device. In the laboratory, 7 volunteers performed 816 actions. Overall sensitivity was 94.1% (95% CI 91.4-96.2%) with a PPV of 99.0% (95% CI 97.3-99.6%) and specificity was 99.0% (95% CI 97.5-99.7%) with a NPV of 94.4% (95% CI 91.9-96.1%). During the pre-planned clinical path phase, 13 volunteers performed 98 planned paths and a total of 967 actions were performed. Overall sensitivity was 94.6% (95% CI 92.2-96.5%) with a PPV of 84.3% (95% CI 81.6-86.7%) and specificity was 82.4% (95% CI 78.7-85.7%) with a NPV of 93.9% (95% CI 91.3-95.7%). During the real clinical conditions phase, 17 healthcare workers were observed for a total of 15 h and 3 min while they performed 485 actions. Sensitivity was 96.8% (95% CI 93.8-98.6%) with a PPV of 98.3% (95% CI 95.6-99.3%) and specificity was 98.3% (95% CI 95.7-99.5%) with a NPV of 96.8% (95% CI 93.9-98.4%). Smartrub® is a highly reliable device for capturing hand hygiene actions under a range of conditions, from the laboratory to clinical care activities.

Sections du résumé

BACKGROUND
We developed SmartRub® powered by iQati®, an electronic device composed of a wristband and an alcohol-based handrub pocket-sized dispenser that measures and provides feedback on the duration of hand friction and the volume poured during each hand hygiene action. We aimed to assess the accuracy of SmartRub®.
METHODS
The specificity, sensitivity, positive and negative predictive values (PPV and NPV) of SmartRub® were assessed in a 3-phased experiment: (1) laboratory-controlled conditions with volunteers; (2) pre-planned clinical path with volunteers and (3) real clinical conditions with healthcare workers. The accuracy of SmartRub® was evaluated by quantifying its ability to correctly capture true hand hygiene actions and to not record other actions performed while wearing the device.
RESULTS
In the laboratory, 7 volunteers performed 816 actions. Overall sensitivity was 94.1% (95% CI 91.4-96.2%) with a PPV of 99.0% (95% CI 97.3-99.6%) and specificity was 99.0% (95% CI 97.5-99.7%) with a NPV of 94.4% (95% CI 91.9-96.1%). During the pre-planned clinical path phase, 13 volunteers performed 98 planned paths and a total of 967 actions were performed. Overall sensitivity was 94.6% (95% CI 92.2-96.5%) with a PPV of 84.3% (95% CI 81.6-86.7%) and specificity was 82.4% (95% CI 78.7-85.7%) with a NPV of 93.9% (95% CI 91.3-95.7%). During the real clinical conditions phase, 17 healthcare workers were observed for a total of 15 h and 3 min while they performed 485 actions. Sensitivity was 96.8% (95% CI 93.8-98.6%) with a PPV of 98.3% (95% CI 95.6-99.3%) and specificity was 98.3% (95% CI 95.7-99.5%) with a NPV of 96.8% (95% CI 93.9-98.4%).
CONCLUSIONS
Smartrub® is a highly reliable device for capturing hand hygiene actions under a range of conditions, from the laboratory to clinical care activities.

Identifiants

pubmed: 34742337
doi: 10.1186/s13756-021-01026-2
pii: 10.1186/s13756-021-01026-2
pmc: PMC8572444
doi:

Substances chimiques

Hand Sanitizers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

158

Informations de copyright

© 2021. The Author(s).

Références

Infect Control Hosp Epidemiol. 2017 May;38(5):547-552
pubmed: 28264743
J Infect Prev. 2017 Nov;18(6):278-287
pubmed: 29344097
Am J Infect Control. 2018 Sep;46(9):1032-1035
pubmed: 29655670
Am J Infect Control. 2017 May 1;45(5):464-465
pubmed: 28456319
J Clin Diagn Res. 2016 Oct;10(10):YE01-YE06
pubmed: 27891446
Infect Control Hosp Epidemiol. 2008 Oct;29(10):957-9
pubmed: 18754740
Lancet. 2011 Jan 15;377(9761):228-41
pubmed: 21146207
Am J Infect Control. 2014 Feb;42(2):144-7
pubmed: 24355492
Stat Med. 2007 May 10;26(10):2170-83
pubmed: 16927452
Infect Control Hosp Epidemiol. 2016 Feb;37(2):219-21
pubmed: 26598073
Am J Infect Control. 2014 May;42(5):472-8
pubmed: 24773785
Infect Control Hosp Epidemiol. 2008 Oct;29(10):954-6
pubmed: 18754741
Infect Control Hosp Epidemiol. 2010 Aug;31(8):869-70
pubmed: 20586650
Infect Control Hosp Epidemiol. 2017 Mar;38(3):348-352
pubmed: 27989240
Am J Infect Control. 2017 May 1;45(5):528-535
pubmed: 28456322

Auteurs

Chloé Guitart (C)

Infection Control Programme and WHO Collaborating Centre On Patient Safety - Infection Control and Improving Practices, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.

Yves-Alain Robert (YA)

iQati, Sion, Switzerland.

Nasim Lotfinejad (N)

Infection Control Programme and WHO Collaborating Centre On Patient Safety - Infection Control and Improving Practices, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.

Simon Fourquier (S)

Haute école du paysage, d'ingénierie et d'architecture de Genève (HEPIA), Geneva, Switzerland.

Yves Martin (Y)

Infection Control Programme and WHO Collaborating Centre On Patient Safety - Infection Control and Improving Practices, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
iQati, Sion, Switzerland.

Daniela Pires (D)

Infection Control Programme and WHO Collaborating Centre On Patient Safety - Infection Control and Improving Practices, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.

Julien Sauser (J)

Infection Control Programme and WHO Collaborating Centre On Patient Safety - Infection Control and Improving Practices, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.

René Beuchat (R)

Haute école du paysage, d'ingénierie et d'architecture de Genève (HEPIA), Geneva, Switzerland.

Didier Pittet (D)

Infection Control Programme and WHO Collaborating Centre On Patient Safety - Infection Control and Improving Practices, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland. didier.pittet@hcuge.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH